United Kingdom experience with alendronate and oesophageal reactions
- PMID: 9667093
- PMCID: PMC1410040
United Kingdom experience with alendronate and oesophageal reactions
Abstract
Alendronate is indicated for the treatment of osteoporosis in post-menopausal women. Although the drug has been associated with reports of severe oesophagitis, there have been no studies establishing the incidence of such reactions. Information was collected on 1523 patients included in a study conducted by means of prescription-event monitoring. Dyspepsia, nausea/vomiting, and abdominal pain were the most frequently reported events in the first month of treatment. After follow-up, 20 patients (1.3%) experienced oesophageal events that were considered to be possibly related to alendronate.
Similar articles
-
Pharmacovigilance study of alendronate in England.Osteoporos Int. 2003 Jul;14(6):507-14. doi: 10.1007/s00198-003-1399-y. Epub 2003 Apr 23. Osteoporos Int. 2003. PMID: 12730757
-
[Drug-induced esophagitis: can stringent indications help prevent this disease picture?].Z Gastroenterol. 1997 Jun;35(6):525-7. Z Gastroenterol. 1997. PMID: 9281245 German. No abstract available.
-
[Alendronate-induced severe esophagitis. A rare and severe reversible side-effect illustrated by three case reports].Lakartidningen. 1998 Aug 26;95(35):3676-80. Lakartidningen. 1998. PMID: 9748782 Swedish.
-
[Alendronate-induced esophagitis. A report of 2 cases].Recenti Prog Med. 1997 May;88(5):223-5. Recenti Prog Med. 1997. PMID: 9244956 Review. Italian.
-
The clinical tolerability profile of alendronate.Int J Clin Pract Suppl. 1999 Apr;101:51-61. Int J Clin Pract Suppl. 1999. PMID: 12669741 Review.
Cited by
-
Pharmacological management of osteoporosis in postmenopausal women: a comparative review.Drugs Aging. 1999 Nov;15(5):349-63. doi: 10.2165/00002512-199915050-00003. Drugs Aging. 1999. PMID: 10600043 Review.
-
A study of codispensing with sodium alendronate in Australia.Br J Clin Pharmacol. 2006 Apr;61(4):470-3. doi: 10.1111/j.1365-2125.2006.02592.x. Br J Clin Pharmacol. 2006. PMID: 16542209 Free PMC article.
-
Alendronate: an update of its use in osteoporosis.Drugs. 2001;61(7):999-1039. doi: 10.2165/00003495-200161070-00010. Drugs. 2001. PMID: 11434454 Review.
-
Iatrogenic esophagitis.Curr Gastroenterol Rep. 2000 Jun;2(3):224-9. doi: 10.1007/s11894-000-0065-1. Curr Gastroenterol Rep. 2000. PMID: 10957934 Review.
-
A Prospective Open-Label Observational Study of a Buffered Soluble 70 mg Alendronate Effervescent Tablet on Upper Gastrointestinal Safety and Medication Errors: The GastroPASS Study.JBMR Plus. 2021 May 17;5(7):e10510. doi: 10.1002/jbm4.10510. eCollection 2021 Jul. JBMR Plus. 2021. PMID: 34258506 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical